First Trust Advisors LP Grows Stock Position in Chemed Corporation $CHE

Key Points

• First Trust Advisors LP raised its Chemed stake 16.7% in Q3 to 175,179 shares—about 1.24% of the company—valued at roughly $78.44 million.
• Chemed missed quarterly estimates (EPS $6.42 vs. $7.02 expected; revenue $639.34M vs. $659.09M) but provided FY2026 guidance of EPS 23.25–24.25.
• Analyst sentiment is mixed: the stock has an average rating of Hold and a $498 average price target after several downgrades, including Zacks' "strong sell."

First Trust Advisors LP increased its stake in Chemed Corporation (NYSE:CHE - Free Report) by 16.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 175,179 shares of the company's stock after acquiring an additional 25,047 shares during the period. First Trust Advisors LP owned about 1.24% of Chemed worth $78,435,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of CHE. Smartleaf Asset Management LLC increased its stake in Chemed by 71.4% in the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company's stock worth $27,000 after purchasing an additional 25 shares during the period. First Horizon Corp purchased a new position in shares of Chemed in the third quarter worth $31,000. Pilgrim Partners Asia Pte Ltd bought a new stake in Chemed during the 3rd quarter valued at $45,000. Parkside Financial Bank & Trust boosted its position in Chemed by 86.3% during the 2nd quarter. Parkside Financial Bank & Trust now owns 95 shares of the company's stock valued at $46,000 after buying an additional 44 shares during the period. Finally, HM Payson & Co. boosted its position in Chemed by 35.5% during the 3rd quarter. HM Payson & Co. now owns 103 shares of the company's stock valued at $46,000 after buying an additional 27 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have recently commented on CHE shares. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Chemed in a research note on Wednesday, January 21st. Zacks Research cut Chemed from a "hold" rating to a "strong sell" rating in a report on Wednesday, March 4th. Royal Bank Of Canada reissued a "sector perform" rating and set a $422.00 target price (down from $572.00) on shares of Chemed in a research note on Friday, February 27th. Jefferies Financial Group lowered Chemed from a "buy" rating to a "hold" rating in a research note on Thursday, January 22nd. Finally, Oppenheimer reduced their price objective on shares of Chemed from $580.00 to $500.00 and set an "outperform" rating on the stock in a research report on Friday, February 27th. Two investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Chemed has an average rating of "Hold" and an average price target of $498.00.

Chemed Stock Down 1.2%

Shares of CHE stock opened at $403.16 on Tuesday. The business's fifty day moving average is $443.59 and its 200 day moving average is $442.32. The stock has a market cap of $5.55 billion, a price-to-earnings ratio of 21.95, a PEG ratio of 1.62 and a beta of 0.47. Chemed Corporation has a twelve month low of $385.00 and a twelve month high of $623.60.

Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings data on Wednesday, February 25th. The company reported $6.42 EPS for the quarter, missing the consensus estimate of $7.02 by ($0.60). The firm had revenue of $639.34 million for the quarter, compared to analysts' expectations of $659.09 million. Chemed had a net margin of 10.48% and a return on equity of 25.66%. The business's quarterly revenue was down .1% compared to the same quarter last year. During the same period in the prior year, the business posted $6.83 EPS. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. Equities research analysts expect that Chemed Corporation will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Stockholders of record on Monday, February 23rd will be issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Monday, February 23rd. Chemed's dividend payout ratio (DPR) is presently 13.06%.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.